Indo Pureco Pratama Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Indo Pureco Pratama Tbk. trades at Rp14 (market cap 64.4B), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 10.7× Indo Pureco Pratama Tbk.'s market cap. Which is the better fit depends on your goals.
| IPPE | LABS | |
|---|---|---|
Market Cap | 64.4B | 691.25B |
Volume | — | 635.5K |
Lot | — | 6.36K |
Turnover | — | 110.15M |
Average Price | — | 173.33 |
Value | — | 110.15M |
Indicative Equilibrium Price | — | 174 |
Indicative Equilibrium Volume | — | 50 |
Trailing returns across standard periods
Latest headlines on both assets
PT Indo Pureco Pratama Tbk ("the Company") was established based on Notarial Deed No. 839 dated March 20, 2019, by Joice Hapsari Fendrini, S.H., M.Kn., Notary in Subang. The Company started its commercial operations in March 2019. The Company has coconut flesh processing factory located at Balimbing, Sub-District Pagaden Barat, District Subang, West Java, Indonesia.
Read more on IPPE →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →